Literature DB >> 28593338

[Diagnostic workup and therapy of acute venous diseases].

T Silber1, K Schweinzer2, A Strölin2.   

Abstract

Acute venous diseases, especially deep leg and pelvic vein thrombosis, present an angiological emergency and can lead to acute life-threatening events such as pulmonary embolism. Long-term consequences may be postthrombotic syndromes. In addition to stroke and myocardial infarction, deep leg and pelvic vein thrombosis are one of the most common cardiovascular diseases. Early diagnosis and rapid initiation of therapy are important.

Entities:  

Keywords:  Anticoagulation; Deep vein thrombosis; Phlebology; Thrombophlebitis; Thrombosis

Mesh:

Substances:

Year:  2017        PMID: 28593338     DOI: 10.1007/s00105-017-4006-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  27 in total

1.  Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system.

Authors:  V Sullivan; P M Denk; S S Sonnad; M J Eagleton; T W Wakefield
Journal:  J Am Coll Surg       Date:  2001-11       Impact factor: 6.113

2.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Authors:  H Decousus; A Leizorovicz; F Parent; Y Page; B Tardy; P Girard; S Laporte; R Faivre; B Charbonnier; F G Barral; Y Huet; G Simonneau
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

3.  Endovenous therapy for deep venous thrombosis: the TORPEDO trial.

Authors:  Mohsen Sharifi; Mahshid Mehdipour; Curt Bay; Gary Smith; Jalaladdin Sharifi
Journal:  Catheter Cardiovasc Interv       Date:  2010-09-01       Impact factor: 2.692

4.  Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.

Authors:  H Partsch; W Blättler
Journal:  J Vasc Surg       Date:  2000-11       Impact factor: 4.268

5.  Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study.

Authors:  P Frappé; A Buchmuller-Cordier; L Bertoletti; C Bonithon-Kopp; S Couzan; P Lafond; A Leizorovicz; A Merah; E Presles; P Preynat; B Tardy; H Décousus
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

Review 6.  Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis.

Authors:  Stacy A Johnson; Scott M Stevens; Scott C Woller; Erica Lake; Marco Donadini; Ji Cheng; José Labarère; James D Douketis
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

Review 7.  Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?

Authors:  Marc Carrier; Grégoire Le Gal; Philip S Wells; Dean Fergusson; Tim Ramsay; Marc A Rodger
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

8.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

9.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

10.  Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study.

Authors:  N S Gibson; S M Schellong; D Y El Kheir; J Beyer-Westendorf; A S Gallus; S McRae; R E G Schutgens; F Piovella; V E A Gerdes; H R Buller
Journal:  J Thromb Haemost       Date:  2009-10-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.